Patents Assigned to Histogenics Corporation
  • Publication number: 20220265900
    Abstract: The invention relates to implantable systems for repairing and restoring cartilage. The invention provides methods and products for cartilage repair that use universal chondrocytes. A universal cell line includes cells such as universal chondrocytes that are not immunogenic or allergenic and can be grown in products suitable for use in a number of different people. Use of the universal chondrocytes allows for new processes and products. Where prior art autologous neocartilage constructs required many small reactors (e.g., at least one culture dish per patient to grow one 34 mm disc per patient), using a universal cell line allows, for example, one large batch of cartilage or neocartilage to be made under uniform conditions.
    Type: Application
    Filed: February 10, 2022
    Publication date: August 25, 2022
    Applicant: Histogenics Corporation
    Inventor: Stephen Richard KENNEDY
  • Publication number: 20210246418
    Abstract: A cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof. The matrix suitable for preparation of cellular or acellular implants for growth and de novo formation of an articular hyaline-like cartilage. A gel-matrix composite system comprising collagen-based matrix having a narrowly defined porosity capable of inducing hyaline-like cartilage production from chondrocytes in vivo and in vitro.
    Type: Application
    Filed: January 22, 2021
    Publication date: August 12, 2021
    Applicant: Histogenics Corporation
    Inventors: Robert Lane Smith, Laurence J.B. Tarrant, Akihiko Kusanagi, Hans P.I. Claesson
  • Publication number: 20210161672
    Abstract: An injury or defect in articular cartilage is treated with a matrix implant that is applied above a barrier composition. The polymer-containing barrier composition is applied to the bottom of a cartilage lesion. The barrier composition can block migration of cells, blood, or other material from subchondral bone into the cartilage lesion.
    Type: Application
    Filed: June 10, 2019
    Publication date: June 3, 2021
    Applicant: HISTOGENICS CORPORATION
    Inventor: James KROM
  • Publication number: 20210059805
    Abstract: A method for use of a double-structured tissue implant or a secondary scaffold stand-alone implant for treatment of tissue defects. The double-structured tissue implant comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold. A method of use of a stand-alone secondary scaffold implant or unit for treatment of tissue defects.
    Type: Application
    Filed: November 16, 2020
    Publication date: March 4, 2021
    Applicant: HISTOGENICS CORPORATION
    Inventors: Sonya Shortkroff, Laurence J.B. Tarrant, Eric J. Roos, Robert Lane Smith, Hans P.I. Claesson
  • Patent number: 10900017
    Abstract: A cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof. The matrix suitable for preparation of cellular or acellular implants for growth and de novo formation of an articular hyaline-like cartilage. A gel-matrix composite system comprising collagen-based matrix having a narrowly defined porosity capable of inducing hyaline-like cartilage production from chondrocytes in vivo and in vitro.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: January 26, 2021
    Assignee: HISTOGENICS CORPORATION
    Inventors: Robert Lane Smith, Laurence J. B. Tarrant, Akihiko Kusanagi, Hans P. I. Claesson
  • Patent number: 10842610
    Abstract: A method for use of a double-structured tissue implant or a secondary scaffold stand-alone implant for treatment of tissue defects. The double-structured tissue implant comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold. A method of use of a stand-alone secondary scaffold implant or unit for treatment of tissue defects.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: November 24, 2020
    Assignee: Histogenics Corporation
    Inventors: Sonya Shortkroff, Laurence J. B. Tarrant, Eric J. Roos, Robert Lane Smith, Hans P. I. Claesson
  • Publication number: 20200224155
    Abstract: A cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof. The matrix suitable for preparation of cellular or acellular implants for growth and de novo formation of an articular hyaline-like cartilage. A gel-matrix composite system comprising collagen-based matrix having a narrowly defined porosity capable of inducing hyaline-like cartilage production from chondrocytes in vivo and in vitro.
    Type: Application
    Filed: December 6, 2019
    Publication date: July 16, 2020
    Applicant: HISTOGENICS CORPORATION
    Inventors: Robert Lane Smith, Laurence J.B. Tarrant, Akihiko Kusanagi, Hans P.I. Claesson
  • Publication number: 20200093962
    Abstract: Neo-cartilage constructs suitable for implantation into a joint cartilage lesion in situ and a method for repair and restoration of function of injured, traumatized, aged or diseased cartilage. The construct comprises at least chondrocytes incorporated into a support matrix processed according to the algorithm comprising variable hydrostatic or atmospheric pressure or non-pressure conditions, variable rate of perfusion, variable medium composition, variable temperature, variable cell density and variable time to which the chondrocytes are subjected.
    Type: Application
    Filed: July 30, 2019
    Publication date: March 26, 2020
    Applicants: HISTOGENICS CORPORATION, TAKAGI INDUSTRIAL CO. LTD.
    Inventors: Shuichi Mizuno, Akihiko Kusanagi, Laurence J.B. Tarrant, Toshimasa Tokuno, Robert Lane Smith
  • Publication number: 20200086005
    Abstract: The invention relates to implantable systems for repairing and restoring cartilage. The invention provides methods and products for cartilage repair that use universal chondrocytes. A universal cell line includes cells such as universal chondrocytes that are not immunogenic or allergenic and can be grown in products suitable for use in a number of different people. Use of the universal chondrocytes allows for new processes and products. Where prior art autologous neocartilage constructs required many small reactors (e.g., at least one culture dish per patient to grow one 34 mm disc per patient), using a universal cell line allows, for example, one large batch of cartilage or neocartilage to be made under uniform conditions.
    Type: Application
    Filed: April 25, 2019
    Publication date: March 19, 2020
    Applicant: HISTOGENICS CORPORATION
    Inventor: Stephen Richard Kennedy
  • Publication number: 20190321451
    Abstract: The invention generally relates to systems (i.e. constructs) for repairing cartilage and methods for preparing the same that introduce a bioactive agent into a culture medium, suspension, scaffold, solution incorporated into the pores of the scaffold, or combinations thereof. The introduction of a bioactive agent promotes production of neo-cartilage (i.e. immature hyaline cartilage) in the system, both ex-vivo and in-vivo.
    Type: Application
    Filed: July 5, 2019
    Publication date: October 24, 2019
    Applicant: Histogenics Corporation
    Inventors: Laurence J.B. Tarrant, Sonya Shortkroff, Shuichi Mizuno, Akihiko Kusanagi, Toshimasa Tokuno, Robert Lane Smith
  • Publication number: 20190010439
    Abstract: The invention generally relates to containers for cell and tissue culturing with multiple compartments in fluid communication with each other to provide a common culture environment in each of the compartments while maintaining physical separation of cells and tissue therein. The invention further relates to culture containers providing a sterile culture environment with detachably coupleable lids and open access to each compartment within a container.
    Type: Application
    Filed: September 14, 2018
    Publication date: January 10, 2019
    Applicant: Histogenics Corporation
    Inventor: Eric Blahut
  • Patent number: 10077420
    Abstract: The invention generally relates to containers for cell and tissue culturing with multiple compartments in fluid communication with each other to provide a common culture environment in each of the compartments while maintaining physical separation of cells and tissue therein. The invention further relates to culture containers providing a sterile culture environment with detachably coupleable lids and open access to each compartment within a container.
    Type: Grant
    Filed: December 2, 2014
    Date of Patent: September 18, 2018
    Assignee: Histogenics Corporation
    Inventor: Eric Blahut
  • Publication number: 20180256309
    Abstract: A method for use of a double-structured tissue implant or a secondary scaffold stand-alone implant for treatment of tissue defects. The double-structured tissue implant comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold. A method of use of a stand-alone secondary scaffold implant or unit for treatment of tissue defects.
    Type: Application
    Filed: May 11, 2018
    Publication date: September 13, 2018
    Applicant: Histogenics Corporation
    Inventors: Sonya Shortkroff, Laurence J.B. Tarrant, Eric J. Roos, Robert Lane Smith, Hans P.I. Claesson
  • Patent number: 9993326
    Abstract: A method for use of a double-structured tissue implant or a secondary scaffold stand alone implant for treatment of tissue defects. The double-structured tissue implant comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold. A method of use of a stand alone secondary scaffold implant or unit for treatment of tissue defects.
    Type: Grant
    Filed: August 25, 2015
    Date of Patent: June 12, 2018
    Assignee: Histogenics Corporation
    Inventors: Sonya Shortkroff, Laurence J. B. Tarrant, Eric J. Roos, Robert Lane Smith, Hans P. I. Claesson
  • Publication number: 20170312391
    Abstract: A double-structured tissue implant and a method for preparation and use thereof for implantation into tissue defects. The double-structured tissue implant comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold. A stand alone secondary scaffold implant or unit. A process for preparation of the double-structured implant or the stand alone secondary scaffold comprising lyophilization and dehydrothermal treatment.
    Type: Application
    Filed: June 23, 2017
    Publication date: November 2, 2017
    Applicant: Histogenics Corporation
    Inventors: Hans Peter Ingemar Claesson, Laurence J.B. Tarrant, Robert Lane Smith, Sonya Shortkroff
  • Patent number: 9701940
    Abstract: A cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof. The matrix suitable for preparation of cellular or acellular implants for growth and de novo formation of an articular hyaline-like cartilage. A gel-matrix composite system comprising collagen-based matrix having a narrowly defined porosity capable of inducing hyaline-like cartilage production from chondrocytes in vivo and in vitro.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: July 11, 2017
    Assignee: Histogenics Corporation
    Inventors: R. Lane Smith, Laurence J. B. Tarrant, Akihiko Kusanagi, Hans P. I. Claesson
  • Patent number: 9687590
    Abstract: A double-structured tissue implant and a method for preparation and use thereof for implantation into tissue defects. The double-structured tissue implant comprising a primary scaffold comprised of collagen and a secondary scaffold comprising a soluble collagen solution in combination with a surfactant generated and positioned within the primary scaffold. A process for preparation of the double-structured implant or the stand alone secondary scaffold comprising lyophilization and dehydrothermal treatment.
    Type: Grant
    Filed: June 21, 2016
    Date of Patent: June 27, 2017
    Assignee: Histogenics Corporation
    Inventors: Hans Peter Ingemar Claesson, Laurence J. B. Tarrant, Robert Lane Smith, Sonya Shortkroff
  • Patent number: 9421304
    Abstract: A double-structured tissue implant (DSTI) and a method for preparation and use thereof for implantation into tissue defects. The double-structured tissue implant for differentiation, growth and transformation of cells, stem cells, mesenchymal stem cells and bone marrow stem cells. DSTI comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold.
    Type: Grant
    Filed: August 20, 2008
    Date of Patent: August 23, 2016
    Assignee: Histogenics Corporation
    Inventors: Sonya Shortkroff, Joseph Khoury, Laurence J. B. Tarrant, Hans P. I. Claesson, Robert Lane Smith
  • Publication number: 20160206787
    Abstract: A double-structured tissue implant (DSTI) and a method for preparation and use thereof for implantation into tissue defects. The double-structured tissue implant for differentiation, growth and transformation of cells, stem cells, mesenchymal stem cells and bone marrow stem cells. DSTI comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold.
    Type: Application
    Filed: August 20, 2008
    Publication date: July 21, 2016
    Applicant: HISTOGENICS CORPORATION
    Inventors: Sonya Shortkroff, Joseph Khoury, Laurence J.B. Tarrant, Hans P.I. Claesson, Robert Lane Smith
  • Patent number: 9393195
    Abstract: Neo-cartilage constructs suitable for implantation into a joint cartilage lesion in situ and a method for repair and restoration of function of injured, traumatized, aged or diseased cartilage. The construct comprises at least chondrocytes incorporated into a support matrix processed according to the algorithm comprising variable hydrostatic or atmospheric pressure or non-pressure conditions, variable rate of perfusion, variable medium composition, variable temperature, variable cell density and variable time to which the chondrocytes are subjected.
    Type: Grant
    Filed: May 21, 2013
    Date of Patent: July 19, 2016
    Assignee: Histogenics Corporation
    Inventors: Shuichi Mizuno, Akihiko Kusanagi, Laurence J. B. Tarrant, Toshimasa Tokuno, Robert Lane Smith